Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
5.31
+0.21 (4.12%)
Aug 10, 2026, 4:00 PM EDT - Market closed

Jupiter Neurosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
32,63526,567---
Market Cap Growth
-92.32%-90.08%----
Enterprise Value
5.542,64126,567000
Last Close Price
5.3176.50802.52---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
76.01120904.00----
PB Ratio
--1438.556367.80---
P/TBV Ratio
--73.82---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
137.08121148.00----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.73-2.890.04-0.38-0.26-0.18
Net Debt / Equity Ratio
-1.74-2.900.05-0.38-0.26-0.13
Net Debt / EBITDA Ratio
-0.35-0.60-0.07-0.57-0.53-0.17
Net Debt / FCF Ratio
-1.41-0.98-0.06-4.62-1.47-0.38
Asset Turnover
0.010.00000.520
Inventory Turnover
0.060.05----
Quick Ratio
-0.0000.000.010.06
Current Ratio
0.020.040.060.000.010.08
Return on Equity (ROE)
595.41%-738.83%299.46%73.91%80.47%107.64%
Return on Assets (ROA)
-292.15%-151.43%-97.35%-2013.22%-759.96%-635.93%
Return on Invested Capital (ROIC)
-131.43%-105.43%-72.95%-187.21%-259.60%-958.13%
Return on Capital Employed (ROCE)
602.16%-754.53%432.33%61.21%57.03%88.74%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-15.57%-20.31%-9.01%98.67%-7.56%-4.25%
Total Shareholder Return
-15.57%-20.31%-9.01%98.67%-7.56%-4.25%
SEC Filings: 10-K · 10-Q